Lung Cancer Clinical Trials

Showing 4081-4100 of 4,288 trials

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

NCT01502202

Intercalated administration of Iressa® (gefitinib) on days 5-18 of chemotherapy cycle improve the efficacy of Pemetrexed/platinum regimen given as first-line treatment for never-smokers with advanced (stage IIIB/IV) lung adenocarcinoma.

Non Small Cell Lung CancerAdenocarcinoma

National Cancer Center, Korea162 participantsStarted Mar 2012

Goyang-si, Gyenggido, South Korea

COMPLETEDPhase 2

A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer

NCT00887549

Thymidylate synthase (TS) is a substance the body produces naturally. The purpose of this research is to determine if there is a link between TS production and how well patients respond to treatment of non-squamous non-small cell lung cancer (NSCLC). The aim for the future is that doctors could have a better understanding in advance about which patients might respond well to pemetrexed based on how much TS they produce.

Non-Small Cell Lung Cancer

Eli Lilly and Company70 participantsStarted Apr 2009

Dublin, Ireland • Derby, Derbyshire, United Kingdom • Exeter, Devon, United Kingdom +11 more locations

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer

Related Searches

Oltipraz in the Prevention of Lung Cancer in People Who Smoke

ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study

A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC)

Case Analysis on Real Life Incidence of Photodynamic Therapy (PDT) Safety Outcomes

Randomized Gefitinib Trial

Exercise Study in Patients With Lung Cancer

Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer

Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors

Phase I/II Trial of PTK787 and Pemetrexed With or Without Cisplatin for Lung Cancer

Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis

Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum

Green Tea Extract in Treating Current or Former Smokers With Bronchial Dysplasia

Carboplatin, Ixabepilone, and Cetuximab in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Untreated With Chemotherapy